Post-IPO Equity Biotechnology Companies

Celadon's objective is to improve the quality of life for the most vulnerable people by producing cannabis-based medications.

ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

Forte Biosciences is a biotechnology company that focuses on dermatology.

Entheon is a addiction recovery solution that harnesses and optimizes the therapeutic potential of the DMT molecule.

AccuStem Sciences is a life sciences company dedicated to optimizing outcomes for all patients with cancer.

ChitogenX. is an orthopedic biotechnology company.

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.

TFF Pharmaceuticals is a clinical-stage biopharmaceutical company that develops drug products.

New treatment for blood diseases, such as leukemia and lymphoma.

Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.

Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.

Peak Bio is a biopharmaceutical company that focuses on the drug development to treat Oncology and Inflammatory diseases.

Solana Company is a traded enterprise for digital asset management and neurotechnology innovation.

Paradigm is a global biopharmaceutical company driven to discover to improve patients’ health and quality of life

Vincerx Pharma is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology.

Telomir Pharmaceuticals develops a novel treatment that binds critical metals to interrupt enzyme function.

Aptahem develops aptamer-based drugs for the treatment of acute life-threatening conditions

Imugene is a publicly-listed biotechnology company with operations in America and Europe,

Lucid Diagnostics develops a non-invasive, office based diagnostic test for biomarkers to esophageal cancer.

Rezolute is a clinical-stage biopharma specializing in the development of drug therapies for patients with metabolic and orphan diseases.

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

Grey Matters Health company is focused on developing, in-licensing, and commercializing proprietary innovative.